Skip to main content
TipRanks
Go Ultimate75% OFF

Compare MapLight Therapeutics, Inc. (MPLT) vs. Competitors

38 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
MPLTMapLight Therapeutics, Inc.$6.90$383.47M-1.27-51.03%Moderate BuyUnlock the MPLT analyst price target with TipRanks PremiumMPLTUnlock the MPLT top-analyst price target with TipRanks Premium
SCNIScinai Immunotherapeutics$0.40$546.84K0.00-95.87%―Unlock the SCNI analyst price target with TipRanks PremiumMPLT vs SCNIUnlock the SCNI top-analyst price target with TipRanks Premium
GRIGRI Bio$1.40$3.06M-0.17-97.04%Moderate BuyUnlock the GRI analyst price target with TipRanks PremiumMPLT vs GRIUnlock the GRI top-analyst price target with TipRanks Premium
DRMADermata Therapeutics$0.60$2.95M-0.18-80.51%―Unlock the DRMA analyst price target with TipRanks PremiumMPLT vs DRMAUnlock the DRMA top-analyst price target with TipRanks Premium
AZTRAzitra Inc$0.63$3.80M-0.09-82.77%Moderate BuyUnlock the AZTR analyst price target with TipRanks PremiumMPLT vs AZTRUnlock the AZTR top-analyst price target with TipRanks Premium

Performance Comparison

-100%-50%0%50%100%150%200%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
MPLTMapLight Therapeutics, Inc.6.90-6.79-49.60%
SCNIScinai Immunotherapeutics0.40-9.22-95.80%
GRIGRI Bio1.40-43.40-96.88%
DRMADermata Therapeutics0.60-2.24-78.94%
AZTRAzitra Inc0.63-2.76-81.52%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts